Alicia Cazorla Jiménez

Diagnosis of breast pathology and cytopathology

Research:

• Proposal for an Epidemiological Study of PD-L1 Expression in TNBC Spanish Patients Spanish Registry of PD-L1 in Breast Cancer REG1CAM GEICAM
• Prediction of Residual Disease After Neoadjuvant Therapy in HER2-Positive Breast Cancer and Identification of Strategies to Overcome Resistance. Carlos III Health Institute. Reference number: PI21/00142
• Multicenter Validation Study of HER2-Low in Breast Cancer by Immunohistochemical Assays with the Platforms: Herceptest (DAKO, Agilent Technologies) and Ventana 4B5 (Ventana Medical Systems, Roche Tissue Diagnostics). AstraZeneca Farmacéutica España, S.A., reference no. EO164-22. Global Ring Study for HER2 IHC Testing in Breast Cancer. Diaceutics Inc. , Reference No. 3876/001.
• Genetic Architecture of Familial Breast Cancer: Completing the Puzzle. Principal Investigator: Ana Laura Osorio Cabrero. Fundación Jiménez Díaz University Hospital, Service: GENETICS Promoter: IIS-Fundación Jiménez Díaz-UAM FJD Code: PI23/01235
• HR+/HER2- (hormone receptor positive/human epidermal growth factor receptor 2 negative) breast cancer: Study of indicators contributing to nodal spread. Principal Investigator: Irène Osorio Silla, Fundación Jiménez Díaz University Hospital, Service: Digestive/General Surgery Promoter: IIS-Fundación Jiménez Díaz-UAM, Protocol code: HR+/HER2

Teaching:

• XLVII Intensive Course for Cytotechnologists and Cytopathologists Spanish Society of Cytology. European University, Villaviciosa de Odón, Madrid, September the 18 th 2024 Oral presentation: Cerebro spinal fluid
• XVI Training course in Basic Breast Pathology for internal doctors of General and Digestive System Surgery and surgical specialists. September 23rd to 25th, 2024. Jiménez Díaz Foundation University Hospital, Madrid. Lecture: Proliferative and premalignant lesions of the breast.

• - Squamous cell carcinoma arising from an epidermal inclusion cyst in breast: An extremely rare diagnosis. Sergio Hernández-Villafranca, Irene Osorio, Sergio Salido, Siyuan Qian, Juan Bernar, Alicia Cazorla Jiménez, Laura Astilleros Blanco de Córdova, Ricardo Pardo. Breast J. 2021 Feb; 27(2):176-177. doi: 10.1111/tbj.14155. Epub 2021 Feb 8.
• - CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study. Kang EY et al. Cancer. 2023 Mar 1; 129(5):697-713.
• Tumor-Infiltrating Lymphocytes and Immune Response in HER2-Positive Breast Cancer. Luque M, Sanz-Álvarez M, Morales-Gallego M, Madoz-Gúrpide J, Zazo S, Domínguez C, Cazorla A, Izarzugaza Y, Arranz JL, Cristóbal I, Rojo F. Cancers (Basel). 2022 Dec 8; 14(24):6034

65th Congress of the Spanish Society of Endocrinology and Nutrition. Oviedo, October 18, 2024

• Poster: Risks of malignancy in thyroid nodules with Bethesda IV cytology in a tertiary care center and possible associated factors. Cárdenas-Salas, Jersey-Jair; Cornejo Ladrero, José Ignacio; Reina Durán, Teresa; Cazorla Jiménez, Alicia; Barrio Dorado, María Pilar; Vélez Dorado, María de los Ángeles; Miguélez González, María; Luca, Bogdana; Vázquez Martínez Clotilde; Gargallo Fernández, Manuel.

• Best original paper from the Journal of Senology and Breast Pathology 2003: "Morphology and Immunophenotype of Breast and Ovarian Cancer in Patients Carrying BRCA-1 and BRCA-2 Mutations." Rev. Senología and Patol Mam 2002; 15(2):53-63. A Cazorla, A Osorio, A Martínez, J Benítez, JM San Román, C Rivas.
• Honorary Diploma for doctoral thesis awarded by the Jiménez Díaz Foundation, in March 2005 (Awards for Clinical Biomedical Research).